We are monitoring the impact of COVID-19 on Latin America Bipolar Disorder Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7948
Share on
Share on

Latin America Bipolar Disorder Market Research Report – Segmented By Type, Mechanism Of Action, Drug Class & Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7948
Pages: 145

The size of the Bipolar Disorder Market in Latin America was valued at around USD 0.55 million in 2021 and is estimated to grow at a CAGR of 1.87% to reach USD 0.60 million by 2026. The increasing stress level among the populace in these regions and other factors such as increasing awareness about bipolar disorder and the governments' steps to increase mental healthcare in these regions are expected to be the significant drivers of market growth in this region.

Y-O-Y growth in the incidence of bipolar disorders, growth in the R & D funds, and rise in chronic disease incidences are majorly fuelling the Latin American bipolar disorder market growth. Initiatives by government and non-government organizations in improving the healthcare infrastructure and rise in outgoings for healthcare in offering developed solutions are leveling up the market's growth rate.

Insufficient amenities for the diagnosis of bipolar disorder and strict government rules are limiting the market demand. Medications used to treat bipolar disorders may have side effects restricting the bipolar disorder market in Latin America.

This research report on the Latin American Bipolar Disorder Market has been segmented and sub-segmented into the following categories:

 By Type:

  • Bipolar I Disorder
  • Bipolar II Disorder
  • Cyclothymic Disorder

By Mechanism of Action:

  • Monoamine Oxidase Inhibitors
  • Tricyclic Antidepressants
  • Benzodiazepines
  • Serotonin-norepinephrine Reuptake Inhibitors
  • Beta-Blockers
  • Selective Serotonin Reuptake Inhibitors
  • Others

By Drug Class:

  • Antianxiety Drugs
  • Mood Stabilizers
  • Antidepressant Drugs
  • Antipsychotic Drugs
  • Anticonvulsants

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Latin American Bipolar disorder market is estimated to rise by geography at a steady pace during the forecast period. Latin American governments have organized some campaigns to bring awareness among the people, propelling the bipolar disorders market. Brazil, Argentina, Chile, and Mexico are expected to have substantial market growth in the upcoming years in the forthcoming years.

Key players in the Latin America Bipolar disorder market are Gedeon Richter, Indivior, AstraZeneca, Janssen Pharmaceuticals, Lundbeck, Bristol-Myers Squibb, Ostuca Holdings Co. Ltd., Glaxo SmithKline (GSK), Allergan Plc, Pfizer, Inc and AbbVie, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Method                       

                                5.1.1 Introduction           

                                5.1.2 Genotypic               

                                5.1.3 Proteomics-based               

                                5.1.4 Phenotypic             

                                5.1.5  Y-o-Y Growth Analysis, By Method              

                                5.1.6  Market Attractiveness Analysis, By Method            

                                5.1.7  Market Share Analysis, By Method             

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 F&B            

                                5.2.3 Diagnostic

                                5.2.4 Pharmaceutical     

                                5.2.5 Environmental       

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 Product                        

                                5.3.1 Introduction           

                                5.3.2 Identification Services        

                                5.3.3 Consumables         

                                5.3.4 Instruments           

                                5.3.5 Y-o-Y Growth Analysis, By Products and Services   

                                5.3.6  Market Attractiveness Analysis, By Products and Services

                                5.3.7  Market Share Analysis, By Products and Services  

                5.4 End User                      

                                5.4.1 Food Manufacturing Industries      

                                5.4.2 Pharmaceutical Companies              

                                5.4.3 Hospitals and Diagnostic Centres   

                                5.4.4 Other End users    

                                5.3.5 Y-o-Y Growth Analysis, By End User             

                                5.3.6  Market Attractiveness Analysis, By End User          

                                5.3.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Method

                                                6.1.3.3 By Application

                                                6.1.3.4 By Product

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Method

                                                6.1.4.3 By Application

                                                6.1.4.4 By Product

                                                6.1.4.5 By End user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Method

                                                6.1.5.3 By Application

                                                6.1.5.4 By Product

                                                6.1.5.5 By End user

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Shimadzu Corporation                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Dickinson & Company                            

                8.3 Biolog Inc.                   

                8.4 Merck KGaA                               

                8.5 IEH Laboratories & Consulting Group                              

                8.6 Trivitron Healthcare                

                8.7 Laboratory Corporation of America Holdings                               

                8.8 Thermo Fisher Scientific Inc.                               

                8.9 Bruker Corporation                 

                8.10 Charles River Laboratories                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, by  Drug type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Latin America Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  2. Latin America Bipolar I Disorder Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Bipolar II Disorder Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Cyclothymic Disorder Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  6. Latin America Monoamine Oxidase Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Tricyclic Antidepressants Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Benzodiazepines Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Serotonin-norepinephrine Reuptake Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  10. Latin America Beta-Blockers Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Selective Serotonin Reuptake Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  13. Latin America Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  14. Latin America Antianxiety Drugs Market, By Region, From 2021 to 2026 (USD Million)
  15. Latin America Mood Stabilizers Market, By Region, From 2021 to 2026 (USD Million)
  16. Latin America Antidepressant Drugs Market, By Region, From 2021 to 2026 (USD Million)
  17. Latin America Antipsychotic Drugs Market, By Region, From 2021 to 2026 (USD Million)
  18. Latin America Anticonvulsants Market, By Region, From 2021 to 2026 (USD Million)
  19. Brazil Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  20. Brazil Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  21. Brazil Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  22. Argentina Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  23. Argentina Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  24. Argentina Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  25. Mexico Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  26. Mexico Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  27. Mexico Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  28. Rest of Latin America Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  29. Rest of Latin America Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  30. Rest of Latin America Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample